COVID-19 does not stop good practice in smoking cessation: Safe use of CO analyzer for smokers in the Covid era

Munarini E, Veronese C, Ogliari AC, Allegri F, Bolchi MG, Boffi R.

The Paradox of the Low Prevalence of Current Smokers Among Covid-19 Patients Hospitalized in Non-Intensive Care Wards: Results From an Italian Multicenter Case-Control Study

Meini S, Fortini A, Andreini R, Sechi LA, Tascini C.

The Effect of Smoking on COVID-19 Symptom Severity: Systematic Review and Meta-Analysis

Gülsen A, Yigitbas BA, Uslu B, Drömann D, Kilinc O.

Self-Reported Alcohol, Tobacco, and Cannabis Use during COVID-19 Lockdown Measures: Results from a Web-Based Survey

Vanderbruggen N, Matthys F, Van Laere S, Zeeuws D, Santermans L, Van den Ameele S, Crunelle CL.

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply

Farsalinos K, Barbouni A, Niaura R.

Tobacco Use Cessation in Three Patients Suffering from Psychotic Disorders: The Impact of the COVID-19 Pandemic

Theuerkauff O, Hanak C.

[COVID-19 and changes in smoking behavior]

Underner M, Perriot J, Peiffer G, Jaafari N.

Ageing, sex, obesity, smoking and COVID-19 - truths, myths and speculations

Białas AJ, Kumor-Kisielewska A, Górski P.

COVID-19, smoking and inequalities: a study of 53 002 adults in the UK

Jackson SE, Brown J, Shahab L, Steptoe A, Fancourt D.

Obesity and Smoking as Risk Factors for Invasive Mechanical Ventilation in COVID-19: a Retrospective, Observational Cohort Study

Costa Monteiro AC, Suri R, Emeruwa IO, Stretch RJ, Cortes Lopez RY, Sherman A, Lindsay CC, Fulcher JA, Goodman-Meza D, Sapru A, Buhr RG, Chang SY, Wang T, Qadir N.

Systematic review of the prevalence of current smoking among hospitalized COVID‚Äë19 patients in China: could nicotine be a therapeutic option?

Takagi H.

The United States National Cancer Institute's Coordinated Research Effort on Tobacco Use as a Major Cause of Morbidity and Mortality among People with HIV

Ashare RL, Bernstein SL, Schnoll R, Gross R, Catz SL, Cioe P, Crothers K, Hitsman B, Marhefka SL, McClure JB, Pacek LR, Vidrine DJ, Vilardaga R, Kaufman A, Edelman EJ.

Nicotine treatment and smoking cessation in the era of COVID-19 pandemic: an interesting alliance

Boutou AK, Pitsiou G, Kontakiotis T, Kioumis I.

Association Between Youth Smoking, Electronic Cigarette Use, and Coronavirus Disease 2019

Gaiha SM, Cheng J, Halpern-Felsher B.

Nicotine and the nicotinic cholinergic system in COVID-19

Tizabi Y, Getachew B, Copeland RL, Aschner M.

Is there a smoker's paradox in COVID-19?

Usman MS, Siddiqi TJ, Khan MS, Patel UK, Shahid I, Ahmed J, Kalra A, Michos ED.

Interests in quitting smoking and alcohol during COVID-19 pandemic in India: A Google Trends study

Uvais NA.

Studying smoking benefit in farmer's lung to understand Covid-19

Bellanger AP, Reboux G.

Will the tobacco industry ultimately triumph in the midst of COVID-19 pandemic?: A call for nurses' action in tobacco control

Lee JJ, Wang MP, Yang SC.

Underlying respiratory diseases, specifically COPD, and smoking are associated with severe COVID-19 outcomes: A systematic review and meta-analysis

Sanchez-Ramirez DC, Mackey D.

A putative role for the tobacco mosaic virus in smokers' resistance to COVID-19

de Bernardis E, Busà L.

Smoking, Vaping, and Tobacco Industry During COVID-19 Pandemic: Twitter Data Analysis

Kamiński M, Muth A, Bogdański P.

Smoking and COVID-19: Similar bronchial ACE2 and TMPRSS2 expression and higher TMPRSS4 expression in current versus never smokers

Voinsky I, Gurwitz D.

Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation

Lee AC, Chakladar J, Li WT, Chen C, Chang EY, Wang-Rodriguez J, Ongkeko WM.

The effect of smoking on COVID-19 severity: a systematic review and meta-analysis

Reddy RK, Charles WN, Sklavounos A, Dutt A, Seed PT, Khajuria A.

COVID-19 in Smokeless Tobacco Habitués: Increased Susceptibility and Transmission

Gaunkar RB, Nagarsekar A, Carvalho KM, Jodalli PS, Mascarenhas K.

Response to the Comment 'Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Komiyama M, Hasegawa K.

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019

Rossato M, Di Vincenzo A.

The double-edged relationship between COVID-19 stress and smoking: Implications for smoking cessation

Bommele J, Hopman P, Walters BH, Geboers C, Croes E, Fong GT, Quah ACK, Willemsen M.

The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease

McAlinden KD, Eapen MS PhD, Lu W, Sharma P, Sohal SS.

Tobacco Quit Intentions and Behaviors among Cigar Smokers in the United States in Response to COVID-19

Kowitt SD, Cornacchione Ross J, Jarman KL, Kistler CE, Lazard AJ, Ranney LM, Sheeran P, Thrasher JF, Goldstein AO.

Implementing Smoking Cessation Interventions in a Preoperative Clinic

Etteldorf JR, Robertson S, Taha A.

E-cigarette-Induced Pulmonary Inflammation and Dysregulated Repair are Mediated by nAChR α7 Receptor: Role of nAChR α7 in ACE2 Covid-19 receptor regulation

Wang Q, Sundar I, Li D, Lucas J, Muthumalage T, McDonough S, Rahman I.

A presentation of E-Cigarette vaping associated lung injury (EVALI) caused by THC-Containing electronic smoking device

Galo J, Celli D, Gross D, Holt G, Campos M.

Covid-19 and ex-smokers: an underestimated prognostic factor?

Carrat√π P, Boffi R, Dragonieri S, Munarini E, Veronese C, Portincasa P.

COVID-19 and tobacco - more questions than answers

Edwards R, Munafò M.

Tobacco smoking cessation in mental health services during the COVID-19 pandemic

Seiler NK, Swamy R, Xiao J, Yun Y.

Participation of the nursing workforce to address COVID-19 among people who use alcohol, tobacco, and drugs

Guilamo-Ramos V, Benzekri A, Thimm-Kaiser M, Abram M, Hagan H.

Rapid Scaling Up of Telehealth Treatment for Tobacco-Dependent Cancer Patients During the COVID-19 Outbreak in New York City

Kotsen C, Dilip D, Carter-Harris L, O'Brien M, Whitlock CW, de Leon-Sanchez S, Ostroff JS.

Recent exposure to smoking and COVID-19

Landoni G, Moro M, Belletti A, Rovere-Querini P, Veronesi G, Ruggeri A, Lembo R, Dalessandro G, Galbiati C, Serpa Neto A, Zangrillo A.

The Effect of the COVID-19 Pandemic on Smoking Cessation Success

Kayhan Tetik B, Gedik Tekinemre I, Taş S.

Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice

Grundy EJ, Suddek T, Filippidis FT, Majeed A, Coronini-Cronberg S.

Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis

Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R.

Smoking in critically ill patients with COVID-19: the Australian experience

Plummer MP, Pellegrini B, Burrell AJ, Begum H, Trapani T, Udy AA; SPRINT-SARI Australia Investigators.

Nicotine and smoking in the COVID-19 era

Tajlil A, Ghaffari S, Pourafkari L, Mashayekhi S, Roshanravan N.

The necessity of continuing to ban tobacco use in public places post-COVID-19

El-Awa F, Fraser CP, Adib K, Hammerich A, Abdel Latif N, Fayokun R, Prasad V, Fu D, Vestal G, Schotte K, Gouda H, St Claire S.

Smoking prevalence and COVID-19 in Europe

Tsigaris P, Teixeira da Silva JA.

Age-dependent assessment of genes involved in cellular senescence, telomere and mitochondrial pathways in human lung tissue of smokers, COPD and IPF: Associations with SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 axis

Maremanda KP, Sundar IK, Li D, Rahman I.

Pulmonary toxicity and inflammatory response of e-cigarettes containing medium-chain triglyceride oil and vitamin E acetate: Implications in the pathogenesis of EVALI but independent of SARS-COV-2 COVID-19 related proteins

Muthumalage T, Lucas JH, Wang Q, Lamb T, McGraw MD, Rahman I.

Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes

Münzel T, Hahad O, Kuntic M, Keaney JF, Deanfield JE, Daiber A.

Notes from the Field: E-cigarette, or Vaping, Product Use-Associated Lung Injury Cases During the COVID-19 Response - California, 2020

Armatas C, Heinzerling A, Wilken JA.

'Quit During COVID-19'-staying smokefree in mental health in-patient settings

Patwardhan P, Driscoll R.

Tobacco Smoking a Potential Risk Factor in Transmission of COVID-19 Infection

Ahmed N, Maqsood A, Abduljabbar T, Vohra F.

Sharing Cigarette Smoking and COVID-19 Outbreak in a Party Group

Yasri S, Wiwanitkit V.

No double-edged sword and no doubt about the relation between smoking and COVID-19 severity

Gallus S, Lugo A, Gorini G.

Impact of smoking status on disease severity and mortality of hospitalized patients with COVID-19 infection: a systematic review and meta-analysis

Karanasos A, Aznaouridis K, Latsios G, Synetos A, Plitaria S, Tousoulis D, Toutouzas K.

"COVID-19 and Smoking: How and Why We Implemented a Tobacco Treatment Campaign"

Lang AE, Yakhkind A, Lang AE.

E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation

Wang Q, Sundar IK, Li D, Lucas JH, Muthumalage T, McDonough SR, Rahman I.

A flaw on a meta-analysis of smoking and the severity of COVID-19: the association should have been endorsed

Guo FR.

Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD

Saheb Sharif-Askari N, Saheb Sharif-Askari F, Alabed M, Temsah MH, Al Heialy S, Hamid Q, Halwani R.

Remote Methods for Conducting Tobacco-Focused Clinical Trials

Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ.

Cigarette Smoking and COVID-19: A Complex Interaction

Polverino F.

Reply to: Cigarette Smoking and COVID-19: A Complex Interaction

Cai G, Bossé Y, Xiao F, Kheradmand F, Amos CI.

Smoking behavior and psychological dynamics during COVID-19 social distancing and stay-at-home policies: A survey

Caponnetto P, Inguscio L, Saitta C, Maglia M, Benfatto F, Polosa R.

SARS-CoV-2 COVID-19 susceptibility and lung inflammatory storm by smoking and vaping

Kaur G, Lungarella G, Rahman I.

Smoking and SARS-CoV-2: Are Polish health professionals at higher risk of infection?

Koczkodaj P, Cedzyńska M, Didkowska J.

How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?

Kloc M, Ghobrial RM, Kubiak JZ.

Depression, Anxiety and Stress during COVID-19: Associations with Changes in Physical Activity, Sleep, Tobacco and Alcohol Use in Australian Adults

Stanton R, To QG, Khalesi S, Williams SL, Alley SJ, Thwaite TL, Fenning AS, Vandelanotte C.

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment

Rajput DV.

Comment on "The Prevalence of Olfactory and Gustatory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis"

Lovato A, Antonini A, de Filippis C.

Smoking is Associated with COVID-19 Progression: A Meta-Analysis

Patanavanich R, Glantz SA.

Does active smoking worsen Covid-19?

Carmona-Bayonas A, Jimenez-Fonseca P, Sánchez Arraez Á, Álvarez Manceñido F, Castañón E.

Smokers are actually at a higher risk of dying from covid-19

Wilson C.

Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results

Jj S, N A, E G.

Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19

Kalan ME, Ghobadi H, Taleb ZB, Ward KD, Adham D, Matin S, Fazlzadeh M, Narimani S.

Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?

Archie SR, Cucullo L.

Protecting American Lungs and Reversing Youth Tobacco Epidemic Act

Largent P, Mazyck D.

Smoking amidst the COVID-19 Pandemic - the invisible threat?

Anand S.

Tobacco smoking and COVID-19 infection

van Zyl-Smit RN, Richards G, Leone FT.

Tobacco Use Patterns in five countries during the COVID-19 Lockdown

Yach D.

Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility

Chakladar J, Shende N, Li WT, Rajasekaran M, Chang EY, Ongkeko WM.

Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers

Pino LE, Triana I, Pérez C, Piotrostanalzki A, Ruiz-Patiño A, Lopes G, Cardona AF.

COVID-19 and the nicotinic cholinergic system

Farsalinos K, Angelopoulou A, Alexandris N, Poulas K.

Active smoking and COVID-19: a double-edged sword

Lippi G, Sanchis-Gomar F, Henry BM.

Epidemiological Data From the COVID-19 Outbreak in Spain for the Promotion of Tobacco Smoking Cessation Policies

V√°zquez JC, Redolar-Ripoll D.

COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine

Polosa R, Caci G.

Smoking, ACE-2, and COVID-19: Ongoing Controversies

Leung JM, Sin DD.

COVID-19 and smoking: a high-risk association

Silva ALOD, Moreira JC, Martins SR.

Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking

Engin AB, Engin ED, Engin A.

Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature

Cattaruzza MS, Zagà V, Gallus S, D'Argenio P, Gorini G.

Active smoking and severity of coronavirus disease 2019 (COVID-19): The use of significance testing leads to an erroneous conclusion

Lo E, Lasnier B.

Smoking is Associated with COVID-19 Progression: A Meta-Analysis.

Patanavanich R, Glantz SA.

Could the smoking gun in the fight against Covid-19 be the (rh) ACE2?

Lutchman D.

COVID-19 lockdown and the tobacco product ban in South Africa.

Hookah smoking and COVID-19: call for action.

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis.

Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, Quaderi S, Mandal S, Hurst JR.

Has there been an increased interest in smoking cessation during the first months of the COVID-19 pandemic? A Google Trends study.

Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?

Farsalinos K, Barbouni A, Niaura R.

Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19.

Tindle HA, Newhouse PA, Freiberg MS.

Public health perspectives of smokeless tobacco and areca nut use in the COVID-19 era.

Kaur J, Rinkoo AV.

Active smoking is associated with severity of coronavirus disease 2019 (COVID-19): An update of a meta-analysis.

Smoking Cessation as a Public Health Measure to Limit the Coronavirus Disease 2019 Pandemic.

Smoking and SARS-CoV-2 Disease (COVID-19): Dangerous Liaisons or Confusing Relationships?

Smoking links to the severity of Covid-19: An update of a meta-analysis.

Guo FR.

Reply to: "Current Smoking is Not Associated with COVID-19".

Leung JM, Yang CX, Sin DD.

Smoking Cessation During the COVID-19 Epidemic.

Eisenberg SL, Eisenberg MJ.

Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system.

Farsalinos K, Niaura R, Le Houezec J, Barbouni A, Tsatsakis A, Kouretas D, Vantarakis A, Poulas K.

COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling.

Does Cigarette Smoking Protect Against SARS-CoV-2 Infection?

Propper RE.

Current Smoking is Not Associated with COVID-19.

Rossato M, Russo L, Mazzocut S, Di Vincenzo A, Fioretto P, Vettor R.

COVID-19 and Nicotine as a Mediator of ACE-2.

Leung JM, Yang CX, Sin DD.

Will changes in alcohol and tobacco use be seen during the COVID-19 lockdown?

Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence.

Change in tobacco and electronic cigarette use and motivation to quit in response to COVID-19.

Klemperer EM, West JC, Peasley-Miklus C, Villanti AC.

COVID-19 and Smoking. Is Nicotine the Hidden Link?

Russo P, Bonassi S, Giacconi R, Malavolta M, Tomino C, Maggi F.

Tobacco use and vaping in the COVID-19 era.

Singh AG, Chaturvedi P.

COVID-19 outbreak impact in Spain: A role for tobacco smoking?

[Smoking and coronavirus disease 2019 (COVID-19)].

Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2.

Cai G, Bossé Y, Xiao F, Kheradmand F, Amos CI.

Letter to the Editor Regarding: "An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19)" -Secondhand and Thirdhand Smoke As Potential Sources of COVID-19.

Mahabee-Gittens EM, Merianos AL, Matt GE.

Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic.

Javelle E.

The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis.

Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y, Lin S.

Public health concerns and unsubstantiated claims at the intersection of vaping and COVID-19.

Majmundar A, Allem JP, Cruz TB, Unger JB.

ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19.

Leung JM, Yang CX, Tam A, Shaipanich T, Hackett TL, Singhera GK, Dorscheid DR, Sin DD.

The tobacco industry in the time of COVID-19: time to shut it down?

Hefler M, Gartner CE.

COVID-19: Risk of increase in smoking rates among England's 6 million smokers and relapse among England's 11 million ex-smokers.

Patwardhan P.

Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19).

Brake SJ, Barnsley K, Lu W, McAlinden KD, Eapen MS, Sohal SS.

COVID-19 and smoking.

Berlin I, Thomas D, Le Faou AL, Cornuz J.

COVID-19 and smoking: A systematic review of the evidence.

Vardavas CI, Nikitara K.

Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19).

Lippi G, Henry BM.

COVID-19: delay, mitigate, and communicate.

The Lancet Respiratory Medicine.

Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.

Pung R, Chiew CJ, Young BE, Chin S, Chen MI, Clapham HE, Cook AR, Maurer-Stroh S, Toh MPHS, Poh C, Low M, Lum J, Koh VTJ, Mak TM, Cui L, Lin RVTP, Heng D, Leo YS, Lye DC, Lee VJM; Singapore 2019 Novel Coronavirus Outbreak Research Team..

Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?

Olds JL, Kabbani N.

Sex difference and smoking predisposition in patients with COVID-19.

Cai H.